腹腔镜辅助与开腹D2远端胃切除术治疗中国北方局部进展期胃癌的多中心随机对照试验短期手术结局
该多中心随机对照试验纳入446例cT2-4aN0-3M0局部进展期胃癌患者,1:1随机分配至腹腔镜辅助远端胃切除术(LADG)组或开腹远端胃切除术(ODG)组,主要终点为术后30天内并发症率和死亡率。改良意向性分析显示两组D2淋巴结清扫依从率均为99.5%,总体术后并发症率无显著差异(LADG 13.1% vs ODG 17.7%,P=0.174),两组均无手术相关死亡。结论认为由资质外科医师实施的LADG对于局部进展期胃癌是安全可行的。
要点
- LADG组与ODG组D2淋巴结清扫依从率均为99.5%,两组一致。
- 总体术后并发症率LADG 13.1% vs ODG 17.7%,差异无统计学意义(P=0.174)。
- 两组均无手术相关死亡,LADG短期安全性不劣于开腹手术。
核心结论
- 由资质外科医师实施的腹腔镜辅助远端胃切除术治疗局部进展期胃癌安全可行,短期结局与开腹手术相当。
研究设计与样本
- 多中心随机对照试验,2014年3月至2017年8月纳入446例cT2-4aN0-3M0(AJCC第7版)局部进展期胃癌患者,1:1随机分配至LADG或ODG组。
- 改良意向性分析纳入LADG组222例和ODG组220例,主要终点为术后30天内并发症率和死亡率,次要终点为3年无病生存率。
主要发现
- LADG组与ODG组D2淋巴结清扫依从率均为99.5%(P=1.000)。
- 总体术后并发症率LADG组为13.1%,ODG组为17.7%,差异无统计学意义(P=0.174)。
- 两组均无手术相关死亡。
临床怎么用
- 对于局部进展期胃癌,可由资质外科医师选择腹腔镜辅助远端胃切除术联合D2淋巴结清扫,短期安全性不劣于开腹手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although laparoscopic surgery has been recommended as an optional therapy for patients with early gastric cancer, whether patients with locally advanced gastric cancer (AGC) could benefit from laparoscopy-assisted distal gastrectomy (LADG) with D2 lymphadenectomy remains elusive due to a lack of comprehensive clinical data. To evaluate the efficacy of LADG, we conducted a multi-institutional randomized controlled trial to compare laparoscopy-assisted versus open distal gastrectomy (ODG) for AGC in North China. METHODS: In this RCT, after patients were enrolled according to the eligibility criteria, they were preoperatively assigned to LADG or ODG arm randomly with a 1:1 allocation ratio. The primary endpoint was the morbidity and mortality within 30 postoperative days to evaluate the surgical safety of LADG. The secondary endpoint was 3-year disease-free survival. This trial was registered at ClinicalTrial.gov as NCT02464215. RESULTS: Between March 2014 and August 2017, a total of 446 patients with cT2-4aN0-3M0 (AJCC 7th staging system) were enrolled. Of these, 222 patients underwent LADG and 220 patients underwent ODG were included in the modified intention-to-treat analysis. The compliance rate of D2 lymph node dissection was identical between the LADG and ODG arms (99.5%, P = 1.000). No significant difference was observed regarding the overall postoperative complication rate in two groups (LADG 13.1%, ODG 17.7%, P = 0.174). No operation-related death occurred in both arms. CONCLUSIONS: This trial confirmed that LADG performed by credentialed surgeons was safe and feasible for patients with AGC compared with conventional ODG.
引用
- Wang Z, Xing J, Cai J, et al. Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial. Surg Endosc. 2018. PMID: 30386984. doi:10.1007/s00464-018-6391-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。